SUMMARYIn the sera of patients with Wegener's granulotnatosis (WG). C-ANCA can be detected that are directed against proteinase 3 (PR3|. We have previously observed that C-ANCA interfere with PR3 proteolytic activity and with complexation of PR3 with its major physiologic inhibitor, xi-antitrypsin (aiAT), In the present study we investigated whether this inhibitory effect of C-ANCA on PR3-x,AT complexation correlates with clinical activity of WG. Serial scrum satnples of ci^ht consecutive patients with histologically proven relapses of WG were tested. At the moment of relapse all sera revealed inhibitory aetivity towards PR3-aiAT complexation (median 22"/;,, range IO-59'«i)-Disease activity score (/•-0-87, /'<002) and C-reactive protein (CRP) levels (/--0'66. /'<0-l) correlated with C-ANCA inhibition of PR3 ai AT complexation, while they did not correlate with the C-ANCA titre detected by indireet imrnunotluorescence (IIF) nor with IgG anti-PR3 antibody level measured by ELISA, The inhibitory effeet of C-ANCA on PR3-ai AT complexation had risen significantly at the moment of relapse compared with values 3 months (/'<0-05) and 6 months {P<()0\) before relapse. Eight patients with established WG and positive for C-ANCA but without clinical evidence of relapse served as controls. In this group no inhibitory eflcct of C-ANCA on PR3 H^PKJ complexation was observed in 7/8 patients sera. Sera of one control patient contained moderate C-ANCA inhibitory activity towards PR3-aiAT complexation, which remained at a constant level during the 6 months period of observation. Thus, disease activity in WG appears to be more closely related to C-ANCA inhibitory activity towards PR3-X|AT eomplcxation.